The Battery

  • Curtis F. Holmes
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 188)


THE ICD presents a significant challenge to the battery designer. The battery must be capable of operating at low current drains (for monitoring) for long periods of time, and then be capable of providing high-current pulses (for capacitor charging) when the patient requires defibrillation. As discussed in the Appendix, a typical requirement for monitoring is the delivery of 10 μA (microamperes) for 5 years. A typical requirement for capacitor charging is that the battery provide a current in excess of 2 A, at voltages above 2 V, for periods as long as 10 s. The cell must therefore exhibit high energy density, high current-delivery capability, and low self-discharge (loss of energy due to internal leakages). It must also meet the high standards of safety and reliability required of all implantable power sources. In addition, it is desirable that the battery’s discharge curve provide a state of charge indication which can signal the need for device replacement.


Open Circuit Voltage Vanadium Oxide Charge Time Implantable Defibrillator Loaded Voltage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Horning RJ, Viswanathan S. High rate lithium cell for medical application, Proc. 29th Power Sources Symp., 1980:64–66.Google Scholar
  2. 2.
    Liang CC, Bolster ME, Murphy RM, inventors. Wilson Greatbatch Ltd., assignees. Metal oxide composite cathode material for high energy density batteries; heat treatment. U.S. Patent No. 4,391,729. 1983 Jul 5.Google Scholar
  3. 3.
    Liang CC, Bolster ME, Murphy RM, inventors. Wilson Greatbatch Ltd., assignees. Metal oxide composite cathode material for high energy density batteries. U.S. Patent No. 4,310,609. 1982 Jan 12.Google Scholar
  4. 4.
    Casalot A, Pouchard M, New nonstoichiometric phases of the silver oxide-vanadium pentoxide-vanadium dioxide system. Chemical and crystallographic study. Bull. Soc. Chim. Fr. 1967;10:3817–3820.Google Scholar
  5. 5.
    Takeuchi ES, Piliero P. Lithium/silver vanadium oxide batteries with various silver to vanadium ratios. J Power Sources 1987;21:133–141.CrossRefGoogle Scholar
  6. 6.
    Takeuchi ES, Thiebolt WC. The reduction of silver vanadium oxide in lithium/silver vanadium oxide cells. J Electrochem Soc 1988;135:2691–2694.CrossRefGoogle Scholar
  7. 7.
    Keister P, Mead RT, Muffoletto BC, et al, inventors. Wilson Greatbatch Ltd., assignees. Non-aqueous lithium battery; implantable cardiac defibrillator. U.S. Patent No. 4,830,940. 1989 May 16.Google Scholar
  8. 8.
    Visbisky M, Stinebring RC, Holmes CF. An approach to the reliability of implantable lithium batteries. J Power Sources 1989;26:185–194.CrossRefGoogle Scholar
  9. 9.
    Holmes CF, Visbisky M. Long-term testing of defibrillator batteries. PACE 1991;14:341–345.PubMedCrossRefGoogle Scholar
  10. 10.
    Rodriguez F, Filimonov A, Henning A, et al. Radiation-induced effects in multi-programmable pacemakers and implantable defibrillators. PACE 1991;14:2143–2153.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Curtis F. Holmes

There are no affiliations available

Personalised recommendations